| 发明名称 |
MARKERS FOR THE PREDICTION OF OUTCOME OF ANTHRACYCLINE TREATMENT |
| 摘要 |
The present invention relates to methods for predicting the outcome of anthracycline treatment of cell proliferative disorder patients. This is achieved by determining the expression level of at least one gene selected from the group consisting of PITX2; TFF1 and PLAU. The invention also relates to sequences, oligonucleotides and antibodies which can be used within the described methods.
|
| 申请公布号 |
US2009111707(A1) |
申请公布日期 |
2009.04.30 |
| 申请号 |
US20060067633 |
申请日期 |
2006.09.21 |
| 申请人 |
EPIGENOMICS AG |
发明人 |
FOEKENS JOHN;MARTENS JOHN;EPPENBERGER-CASTORI SERENELLA;VUAROQUEAUX VINCENT;SPYRATOS FREDERIQUE;HARBECK NADIA;SCHMITT MANFRED;HOEFLER HEINZ;MAIER SABINE;WEISS GUNTER;LESCHE RALF;HILDMANN THOMAS;PLUM ACHIM |
| 分类号 |
C40B30/04;C12Q1/68 |
主分类号 |
C40B30/04 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
